XML 132 R118.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidating Financial Information - Condensed Consolidating Statements of Cash Flows (Details) - USD ($)
$ in Millions
1 Months Ended 12 Months Ended
Feb. 21, 2018
Jan. 17, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Consolidated Statements of Cash Flows [Abstract]          
Net cash provided by operating activities     $ 762.4 $ 658.3 $ 640.2
Cash flows from investing activities:          
Acquisition of businesses, net of cash acquired     (143.9) (38.8) (48.1)
Purchases of property and equipment     (254.5) (225.8) (177.7)
Additions to capitalized software costs     (16.0) (19.2) (25.2)
Proceeds from disposal of assets     0.4 12.3 23.9
Proceeds from sale of restricted investments     11.6 4.2 0.1
Purchase of restricted investments     (13.3) (8.5) (1.3)
Funding of intercompany note receivable         0.0
Proceeds from repayment of intercompany note receivable     0.0 0.0 0.0
Other     (8.8) (7.2) (1.7)
Net cash provided by investing activities of discontinued operations     0.0 0.0 0.1
Net cash used in investing activities     (424.5) (283.0) (229.9)
Cash flows from financing activities:          
Principal payments on debt, including pre-payments     (20.6) (129.9) (202.1)
Principal borrowings on intercompany note payable         0.0
Principal borrowings on notes     13.2 0.0 0.0
Principal payments on intercompany notes payable     0.0 0.0 0.0
Borrowings on revolving credit facility     325.0 273.3 335.0
Payments on revolving credit facility     (390.0) (330.3) (313.0)
Principal payments under capital lease obligations     (17.9) (15.3) (13.3)
Repurchases of common stock, including fees and expenses     0.0 (38.1) (65.6)
Dividends paid on common stock     (100.8) (91.5) (83.8)
Purchase of equity interests in consolidated affiliates $ (65.0)   (65.1) 0.0 0.0
Proceeds from exercising stock warrants   $ 26.7 0.0 26.6 0.0
Distributions paid to noncontrolling interests of consolidated affiliates     (75.4) (51.9) (64.9)
Taxes paid on behalf of employees for shares withheld     (8.3) (19.8) (11.6)
Contributions from consolidated affiliates     12.6 20.8 3.5
Other     6.1 (3.8) (0.6)
Change in intercompany advances     0.0 0.0 0.0
Net cash used in financing activities     (321.2) (359.9) (416.4)
Increase in cash, cash equivalents, and restricted cash     16.7 15.4 (6.1)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period   101.4 116.8 101.4 107.5
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period     133.5 116.8 101.4
Reconciliation of Cash, Cash Equivalents, and Restricted Cash          
Cash and cash equivalents at beginning of period   40.5 54.4 40.5 61.6
Restricted cash at beginning of period   60.9 62.4 60.9 45.9
Cash and cash equivalents at end of period     69.2 54.4 40.5
Restricted cash at end of period     59.0 62.4 60.9
Restricted cash included in other long-term assets at end of period     5.3 0.0 0.0
Supplemental schedule of noncash financing activities:          
Conversion of convertible debt     0.0 319.4 0.0
Preferred stock conversion       0.0  
Intercompany note activity         0.0
Eliminating Entries          
Consolidated Statements of Cash Flows [Abstract]          
Net cash provided by operating activities     0.0 0.0 0.0
Cash flows from investing activities:          
Acquisition of businesses, net of cash acquired     0.0 0.0 0.0
Purchases of property and equipment     0.0 0.0 0.0
Additions to capitalized software costs     0.0 0.0 0.0
Proceeds from disposal of assets     0.0 0.0 0.0
Proceeds from sale of restricted investments     0.0 0.0 0.0
Purchase of restricted investments     0.0 0.0 0.0
Funding of intercompany note receivable         22.5
Proceeds from repayment of intercompany note receivable     (87.0) (51.0) (52.0)
Other     0.0 0.0 0.0
Net cash provided by investing activities of discontinued operations         0.0
Net cash used in investing activities     (87.0) (51.0) (29.5)
Cash flows from financing activities:          
Principal payments on debt, including pre-payments     0.0 0.0 0.0
Principal borrowings on intercompany note payable         (22.5)
Principal borrowings on notes     0.0    
Principal payments on intercompany notes payable     87.0 51.0 52.0
Borrowings on revolving credit facility     0.0 0.0 0.0
Payments on revolving credit facility     0.0 0.0 0.0
Principal payments under capital lease obligations     0.0 0.0 0.0
Repurchases of common stock, including fees and expenses       0.0 0.0
Dividends paid on common stock     0.0 0.0 0.0
Purchase of equity interests in consolidated affiliates     0.0    
Proceeds from exercising stock warrants       0.0  
Distributions paid to noncontrolling interests of consolidated affiliates     0.0 0.0 0.0
Taxes paid on behalf of employees for shares withheld     0.0 0.0 0.0
Contributions from consolidated affiliates     0.0 0.0 0.0
Other     0.0 0.0 0.0
Change in intercompany advances     0.0 0.0 0.0
Net cash used in financing activities     87.0 51.0 29.5
Increase in cash, cash equivalents, and restricted cash     0.0 0.0 0.0
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period   0.0 0.0 0.0 0.0
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period     0.0 0.0 0.0
Reconciliation of Cash, Cash Equivalents, and Restricted Cash          
Cash and cash equivalents at beginning of period   0.0 0.0 0.0 0.0
Restricted cash at beginning of period   0.0 0.0 0.0 0.0
Cash and cash equivalents at end of period     0.0 0.0 0.0
Restricted cash at end of period     0.0 0.0 0.0
Restricted cash included in other long-term assets at end of period     0.0    
Supplemental schedule of noncash financing activities:          
Conversion of convertible debt       0.0  
Intercompany note activity     0.0 0.0 0.0
Encompass Health Corporation [Member]          
Consolidated Statements of Cash Flows [Abstract]          
Net cash provided by operating activities     (10.6) 28.7 60.3
Cash flows from investing activities:          
Acquisition of businesses, net of cash acquired     (131.4) (10.9) 0.0
Purchases of property and equipment     (34.1) (39.4) (21.8)
Additions to capitalized software costs     (14.1) (16.3) (22.8)
Proceeds from disposal of assets     0.0 0.0 0.0
Proceeds from sale of restricted investments     0.0 0.0 0.0
Purchase of restricted investments     0.0 0.0 0.0
Funding of intercompany note receivable         (22.5)
Proceeds from repayment of intercompany note receivable     87.0 51.0 52.0
Other     (8.5) (3.7) (3.7)
Net cash provided by investing activities of discontinued operations         0.1
Net cash used in investing activities     (101.1) (19.3) (18.7)
Cash flows from financing activities:          
Principal payments on debt, including pre-payments     (17.6) (126.9) (198.5)
Principal borrowings on intercompany note payable         0.0
Principal borrowings on notes     0.0    
Principal payments on intercompany notes payable     0.0 0.0 0.0
Borrowings on revolving credit facility     325.0 273.3 335.0
Payments on revolving credit facility     (390.0) (330.3) (313.0)
Principal payments under capital lease obligations     0.0 0.0 (0.1)
Repurchases of common stock, including fees and expenses       (38.1) (65.6)
Dividends paid on common stock     (100.7) (91.5) (83.8)
Purchase of equity interests in consolidated affiliates     (65.1)    
Proceeds from exercising stock warrants       26.6  
Distributions paid to noncontrolling interests of consolidated affiliates     0.0 0.0 0.0
Taxes paid on behalf of employees for shares withheld     (7.4) (19.5) (11.6)
Contributions from consolidated affiliates     0.0 0.0 0.0
Other     3.0 (3.1) 1.1
Change in intercompany advances     371.7 313.8 274.3
Net cash used in financing activities     118.9 4.3 (62.2)
Increase in cash, cash equivalents, and restricted cash     7.2 13.7 (20.6)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period   20.6 34.3 20.6 41.2
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period     41.5 34.3 20.6
Reconciliation of Cash, Cash Equivalents, and Restricted Cash          
Cash and cash equivalents at beginning of period   20.6 34.3 20.6 41.2
Restricted cash at beginning of period   0.0 0.0 0.0 0.0
Cash and cash equivalents at end of period     41.5 34.3 20.6
Restricted cash at end of period     0.0 0.0 0.0
Restricted cash included in other long-term assets at end of period     0.0    
Supplemental schedule of noncash financing activities:          
Conversion of convertible debt       319.4  
Intercompany note activity     (136.8) (8.8) (11.7)
Guarantor Subsidiaries          
Consolidated Statements of Cash Flows [Abstract]          
Net cash provided by operating activities     417.8 381.3 327.4
Cash flows from investing activities:          
Acquisition of businesses, net of cash acquired     0.0 0.0 0.0
Purchases of property and equipment     (133.0) (106.1) (77.4)
Additions to capitalized software costs     (0.1) (0.2) (0.2)
Proceeds from disposal of assets     0.0 11.7 0.7
Proceeds from sale of restricted investments     0.0 0.0 0.0
Purchase of restricted investments     0.0 0.0 0.0
Funding of intercompany note receivable         0.0
Proceeds from repayment of intercompany note receivable     0.0 0.0 0.0
Other     2.8 0.0 (0.2)
Net cash provided by investing activities of discontinued operations         0.0
Net cash used in investing activities     (130.3) (94.6) (77.1)
Cash flows from financing activities:          
Principal payments on debt, including pre-payments     0.0 0.0 (1.3)
Principal borrowings on intercompany note payable         0.0
Principal borrowings on notes     0.0    
Principal payments on intercompany notes payable     0.0 0.0 0.0
Borrowings on revolving credit facility     0.0 0.0 0.0
Payments on revolving credit facility     0.0 0.0 0.0
Principal payments under capital lease obligations     (7.6) (6.8) (5.9)
Repurchases of common stock, including fees and expenses       0.0 0.0
Dividends paid on common stock     0.0 0.0 0.0
Purchase of equity interests in consolidated affiliates     0.0    
Proceeds from exercising stock warrants       0.0  
Distributions paid to noncontrolling interests of consolidated affiliates     0.0 0.0 0.0
Taxes paid on behalf of employees for shares withheld     0.0 0.0 0.0
Contributions from consolidated affiliates     0.0 0.0 0.0
Other     0.0 0.0 0.0
Change in intercompany advances     (279.9) (278.6) (242.7)
Net cash used in financing activities     (287.5) (285.4) (249.9)
Increase in cash, cash equivalents, and restricted cash     0.0 1.3 0.4
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period   1.6 2.9 1.6 1.2
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period     2.9 2.9 1.6
Reconciliation of Cash, Cash Equivalents, and Restricted Cash          
Cash and cash equivalents at beginning of period   1.6 2.9 1.6 1.2
Restricted cash at beginning of period   0.0 0.0 0.0 0.0
Cash and cash equivalents at end of period     2.9 2.9 1.6
Restricted cash at end of period     0.0 0.0 0.0
Restricted cash included in other long-term assets at end of period     0.0    
Supplemental schedule of noncash financing activities:          
Conversion of convertible debt       0.0  
Intercompany note activity     0.0 0.0 0.0
Non-Guarantor Subsidiaries          
Consolidated Statements of Cash Flows [Abstract]          
Net cash provided by operating activities     355.2 248.3 252.5
Cash flows from investing activities:          
Acquisition of businesses, net of cash acquired     (12.5) (27.9) (48.1)
Purchases of property and equipment     (87.4) (80.3) (78.5)
Additions to capitalized software costs     (1.8) (2.7) (2.2)
Proceeds from disposal of assets     0.4 0.6 23.2
Proceeds from sale of restricted investments     11.6 4.2 0.1
Purchase of restricted investments     (13.3) (8.5) (1.3)
Funding of intercompany note receivable         0.0
Proceeds from repayment of intercompany note receivable     0.0 0.0 0.0
Other     (3.1) (3.5) 2.2
Net cash provided by investing activities of discontinued operations         0.0
Net cash used in investing activities     (106.1) (118.1) (104.6)
Cash flows from financing activities:          
Principal payments on debt, including pre-payments     (3.0) (3.0) (2.3)
Principal borrowings on intercompany note payable         22.5
Principal borrowings on notes     13.2    
Principal payments on intercompany notes payable     (87.0) (51.0) (52.0)
Borrowings on revolving credit facility     0.0 0.0 0.0
Payments on revolving credit facility     0.0 0.0 0.0
Principal payments under capital lease obligations     (10.3) (8.5) (7.3)
Repurchases of common stock, including fees and expenses       0.0 0.0
Dividends paid on common stock     (0.1) 0.0 0.0
Purchase of equity interests in consolidated affiliates     0.0    
Proceeds from exercising stock warrants       0.0  
Distributions paid to noncontrolling interests of consolidated affiliates     (75.4) (51.9) (64.9)
Taxes paid on behalf of employees for shares withheld     (0.9) (0.3) 0.0
Contributions from consolidated affiliates     12.6 20.8 3.5
Other     3.1 (0.7) (1.7)
Change in intercompany advances     (91.8) (35.2) (31.6)
Net cash used in financing activities     (239.6) (129.8) (133.8)
Increase in cash, cash equivalents, and restricted cash     9.5 0.4 14.1
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period   79.2 79.6 79.2 65.1
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period     89.1 79.6 79.2
Reconciliation of Cash, Cash Equivalents, and Restricted Cash          
Cash and cash equivalents at beginning of period   18.3 17.2 18.3 19.2
Restricted cash at beginning of period   $ 60.9 62.4 60.9 45.9
Cash and cash equivalents at end of period     24.8 17.2 18.3
Restricted cash at end of period     59.0 62.4 60.9
Restricted cash included in other long-term assets at end of period     5.3    
Supplemental schedule of noncash financing activities:          
Conversion of convertible debt       0.0  
Intercompany note activity     $ 136.8 $ 8.8 $ 11.7